Lung cancer is the second most diagnosed cancer in both men and women worldwide. Considering the high mor-tality rate of lung cancer indicating the inadequacy of conventional treatment methods such as surgical resection, chemo-therapy and radiotherapy; new treatment strategies is an emerging area ...
Chemoprevention of Oesophageal Cancer and the AspECT Trial Oesophageal cancer is on the rise and often present in an advanced state. Advances in surgical techniques, chemotherapy and radiotherapy have not changed the prognosis of oesophageal cancer over the last 20 years. With the unravelling of......
significant advancements in the diagnosis and treatment of lung cancer, particularly NSCLC, have been achieved with the help of molecular translational research. Among the hopeful breakthroughs in therapeutic approaches, advances in targeted therapy have brought the most successful outcomes ...
RECENT ADVANCES IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER Lung cancer is the leading cause of cancer death throughout the world. In the U. S., where lung cancer accounts for 28% of all cancer deaths, there are mor... PA Bunn - 中国抗癌协会第六届临床肿瘤协作中心(CSCO)学...
We have also briefly reported on emerging technologies such as vapor ablation of lung parenchyma for lung cancers. Advances in bronchoscopic therapy will bring additional treatment options to patients with peripheral lung malignancies, with putative advantages over other minimally invasive modalities....
In recent years, radiofrequency ablation has been increasingly practiced in the clinical treatment of lung cancer, and great advances have been achieved in this field. The manipulation of the procedure is simple and easy. Moreover, the technique carries fewer complications and less suffering to the...
Numerous cancer-associated deaths are owing to a lack of effective diagnostic and therapeutic approaches. Microfluidic systems for analyzing a low volume of samples offer a precise, quick, and user-friendly technique for cancer diagnosis and treatment. M
SCLC treatment remained relatively unchanged, withchemotherapy remaining the cornerstone of treatment. In this overview we will highlight the recentadvances in the field of staging, surgery, radiotherapy and systemic treatment. Nevertheless, the prognosisremains dismal and there is a pressing need for ne...
Advances in the Diagnosis and Treatment of Non-Small Cell Lung Cancer The diagnostic and therapeutic landscape of non-small cell lung cancer (NSCLC) has changed dramatically in the past 50 years since the Surgeon General's re... RN Pillai,SS Ramalingam - 《Molecular Cancer Therapeutics》 被引...